Compositions and methods for islet cell transplants
US-2024269194-A1 · Aug 15, 2024 · US
US9393272B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9393272-B2 |
| Application number | US-201214237214-A |
| Country | US |
| Kind code | B2 |
| Filing date | Aug 9, 2012 |
| Priority date | Aug 9, 2011 |
| Publication date | Jul 19, 2016 |
| Grant date | Jul 19, 2016 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Microcapsules are described that comprise (a) a liquid aqueous or hydrogel core; (b) a semipermeable membrane surrounding said core; (c) live animal cells (e.g., pancreatic cells) in the core; and (d) oxygen-generating particles in said core, said oxygen-generating particles included in said microcapsules in an amount sufficient to lengthen the duration of viability of said animal cells in said microcapsules. Compositions comprising such microcapsules and uses thereof, such as in treating diabetes, are also described.
Opening claim text (preview).
That which is claimed is: 1. A microcapsule comprising: (a) a liquid aqueous or hydrogel core; (b) a semipermeable membrane layer surrounding said core; (c) live mammalian cells in said core, said cells are human pancreatic islet cells; (d) oxygen-generating particles in said core, said oxygen-generating particles included in said microcapsules in an amount sufficient to lengthen the duration of viability of said animal cells in said microcapsules; wherein said oxygen-generating particles comprise (i) magnesium peroxide, optionally in combination with a biodegradable polymer comprising alginate, and (ii) catalase; (e) an antioxidant, which is trolox; and (f) an auxiliary layer surrounding said semipermeable membrane layer, wherein said auxiliary layer comprises a biodegradable polymer comprised of sodium alginate, said biodegradable polymer containing an angiogenic agent in an amount effective to enhance the growth of blood vessels adjacent said microcapsule. 2. The microcapsule of claim 1 , wherein said angiogenic agent is vascular endothelial growth factor.
containing heavy metals, e.g. hemin, hematin, melarsoprol · CPC title
Polysaccharides, e.g. gums, alginate; Cyclodextrin · CPC title
the carrier being a carbohydrate · CPC title
Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca · CPC title
Pancreas; Islets of Langerhans (Langerhans cells of epidermis A61K35/36) · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.